T

TG Therapeutics, Inc.

274 employees

TG Therapeutics, a biopharmaceutical company, develops agents for the treatment of hematologic malignancies and autoimmune disorders.

Basic info

Industry

biotechnology research

Sectors

umbralisib
hematological malignancies
Biotechnology
ublituximab
Health Care
non-Hodgkin's lymphoma
multiple sclerosis
Therapeutics
b-cell diseases

Date founded

2011

Funding rounds raised

Total raised

$70M

from 1 investors over 1 rounds

T

TG Therapeutics, Inc. raised $70M on January 4, 2022

Investors: Hercules Capital, Inc.

FAQ